SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Tanke Biosciences Corporation (TNBI) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 25/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — TNBI
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2009 |
$-0.05 |
$0.00 |
$-21.67K |
- |
| 2010 |
$0.00 |
$0.00 |
$-29.87K |
- |
| 2011 |
$-0.24 |
$23.83M |
$-3.14M |
-13.2% |
| 2012 |
$-0.02 |
$28.56M |
$-210.25K |
-0.7% |
| 2019 |
$0.00 |
$0.00 |
$0.00 |
- |
| 2020 |
$0.00 |
$0.00 |
$0.00 |
- |
| 2021 |
$-0.06 |
$0.00 |
$-722.98K |
- |
| 2022 |
$-0.01 |
$0.00 |
$-98.15K |
- |
| 2023 |
$0.00 |
$0.00 |
$-82.52K |
- |
| 2024 |
$0.00 |
$0.00 |
$-119.93K |
- |
